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Background. We investigated the predictive value and the relative risk of the evaluation of serum eosinophilic cationic protein
(sECP) and total IgE levels concomitantly in relation to the persistence of wheezing in young children. Methods. The study was
conducted prospectively between January 2007 and December 2010. A hundred and eight children, aged between three months
and four years, with three or more episodes of wheezing, were studied to evaluate the role of eosinophil inﬂammation and its
relation to persistence of wheezing two years later. Results. A statistically signiﬁcant diﬀerence in terms of total IgE and sECP values
was observed between the groups (P<0.05). When measurement of IgE and sECP was assessed concomitantly, the sensitivity was
found to be 92.68%, the negative predictive value was found to be 71.43%, accuracy rate was found to be 84.26%, and the relative
risk was found to be 3.06 in group 1. Conclusions. In this study, we aimed to emphasize the importance of the assessment of sECP
and total IgE concomitantly, as being two noninvasive and easily applicable tests, useful in predicting persistent wheezing in early
childhood.
1.Introduction
Wheezingis amusicalsoundfrequentlyheardduringexpira-
tion.Itisheardintheformofaprolongedwhistleandoccurs
mostly together with diseases that constrict the lower respi-
ratory tract and rarely the upper respiratory tract. Wheezing
is a frequent complaint among patients seeking admission
to hospital. It often occurs in early childhood, although it
may be observed in people of all ages. Chronic or recurrent
wheezing may be caused by several etiological factors. It
is a controversial topic as to whether or not children who
wheeze in their early childhood will also develop asthma in
the future.
Asthmagenerallystartsduringtheﬁrstyearsoflife.How-
ever, young wheezing children are a heterogeneous group.
About 60% of early wheezers suﬀer transitory disease and
becomeasymptomaticwhentheyreach5-6yearsofage,with
only 40% continuing with asthma at this age. Identifying
infants who will go on to develop persistent wheezing
and determining whether inhaled anti-inﬂammatory drugs,
or other treatments, can block the processes leading to
chronic asthma are important challenges in the prevention
of this common disease. Conventional modalities remain
incapable of diagnosing and following up people with
asthma. Respiratory function tests and prick tests, which
are commonly used to establish clinical diagnoses, exhibit
some diﬃculties when applied to young children. Therefore,
assessments directed to eosinophils, which are the essential
cells of inﬂammation, and their products have gained in
importance.ThequantitativemeasurementofECPinserum,
which is a granular eosinophil product, has been reported
to be a speciﬁc indicator of inﬂammation of the respiratory
tract [1, 2]. The levels of sECP, which is one of the leukocytic
granular proteins, have been found to be high during the
course of many active inﬂammatory diseases. sECP, which
is mostly produced by eosinophils, is toxic to the neurons
and to some of the epithelial cell walls. Unlike total IgE,
there is a good correlation between sECP concentration
and clinical ﬁndings. sECP levels do not directly correlate
with the peripheral eosinophil count. However, sECP levels2 ISRN Pediatrics
are closely related to the activity of the eosinophils. Numer-
ous studies report this as a valuable parameter in displaying
inﬂammation of the respiratory tract and eosinophilic
activation in children with asthma [3].
Our study was designed to evaluate the importance of
eosinophilic inﬂammation in wheezing children in the ﬁrst
years of life and to identify factors at the onset of the
disease, including measurement of sECP, as a marker of
eosinophilic inﬂammation, and total IgE, concomitantly, as
possible predictors for the persistence of wheezing at age of 5
years.
2. Patientsand Methods
Study participants were outpatients between three months
and four years of age who came to the Private Fatih
University Sema Application and Research Hospital between
January 2007 and December 2010, having had three or
more episodes of wheezing. Patients with a clinical history
suggestive of other respiratory problems, or heart disease,
those with neonatal pathology, and those who had taken
systemic or inhaled corticosteroids or cromoglycate in the
previous three months were excluded. A hundred and
eight patients (60 boys and 48 girls) were enrolled in the
study. While forming the study and control groups the
patients were not evaluated on the basis of presence of
allergic rhinitis, atopic dermatitis, or a history of mater-
nal asthma. Blood samples were drawn during wheezing
attacks.
Two years later, at a second clinical evaluation, the
children were separated into two groups. We classiﬁed
children as persistent wheezers if they had had at least one
wheezing episode over the past six months (autumn and
winter) or if they had cough or dyspnea with exercise (group
1, persistent wheezers). The second group was children who
had been asymptomatic during the past six months (group
2, transient wheezers).
Measurements of 24mcg\lt and higher were accepted
as high for sECP. Simultaneously, a total IgE measurement
of 15IU\mL and higher was accepted as high for zero
to 12 months, while values of 60IU\mL and higher were
accepted as high for 13 to 60 months. Eosinophilic cationic
protein (ECP) levels in the serum were measured, using the
automated chemiluminescent immunoassay system (Immu-
lite 2000 analyzer) immunologic test analyzer, with the
solid phase, two-site, “chemiluminescent immunometric”
method. Serum total IgE levels were measured with the
electrochemiluminescenceimmunoassayimmunologicaltest
(ECLIA), using the sandwich principle and cobas e601
immunology test analyzer.
3.StatisticalAnalysis
The Number Cruncher Statistical System (NCSS) 2007, the
Power Analysis and Sample Size (PASS), 2008 Statistical
Software (Utah, USA) programs were used for the statistical
analysis. Signiﬁcance was assessed at a level of P<0.05.
Table 1: General baseline characteristics of the study groups.
Study group Control group P value
Male gender 46 (56.1%) 14 (53.8%) P>0.05
Female gender 36 (43.9%) 12 (46.2%) P>0.05
Mean age (years) 2.65 ± 1.86 2.07 ± 2.04 P>0.05
Total IgE 97.1IU\mL 16.9IU\mL P<0.01
sECP 45.9mcg\lt 18.6mcg\lt P<0.01
4. Results
In terms of the patients’ gender distribution, no statistically
signiﬁcant diﬀerence was observed between group 1, which
consisted of 46 male and 36 female patients, and group 2,
whichconsistedof14maleand12femalepatients(P<0.05).
In terms of age distribution, while the mean age of group 1
was found to be 2.65 ±1.86 years and the mean age of group
2w a sf o u n dt ob e2 .07±2.04 years, no statistically signiﬁcant
diﬀerence was observed between the two groups (P>0.05).
The mean sECP values were found to be 45.9 in group 1 and
18.6 in group 2. The IgE value was found to be 97.1 in group
1a n d1 6 . 9i ng r o u p2( P<0.01) (Table 1).
In relation to the measurement of ECP, 24mcg/lt and
higher was taken as high, and a statistically signiﬁcant
diﬀerence was observed between the rate of 68.3% in group
1 and of 15.4% in group 2 (P<0.01). When considering
IgE levels of 15IU/mL and higher to be high for zero to 12
months and 60IU/mL and higher to be high for 13 to 60
months, a signiﬁcant diﬀerence was detected between the
rate of 54.9% for total IgE in group 1 and the rate of 30.8%
in group 2 (P<0.05).
While the probability of one of the measurements of IgE
and/or sECP being high in group 1 was found to be 92.7%
and42.3%ingroup2,astatisticallysigniﬁcantdiﬀerencewas
found between the two groups (P<0.01). The evaluation of
total IgE and sECP concomitantly revealed a sensitivity rate
of92.68%,anegativepredictivevalueof71.48%,anaccuracy
rate of 84.26%, with a highest relative risk of 3.06. The sECP
measurement displayed a highest speciﬁcity rate of 84.62%,
and a positive predictive value of 93.33%. At followup after
two years, 73.5% of the patients in group 1 and 18.5% of
the patients in group 2 showed persistence in wheezing. A
statistically signiﬁcant diﬀerence was found between the two
groups in terms of the rate of persistent wheezing (P<0.01)
(Table 2).
5. Discussion
The degree to which eosinophil-mediated inﬂammation is
involved in young children with asthma and the extent
to which such inﬂammation will determine the prognosis
remain unknown. Serum ECP is a mediator of the allergic
inﬂammation, released by the eosinophils and activated by
the mediation of IgE [4]. Numerous studies report sECP
as a helpful parameter in displaying inﬂammation of the
respiratory tract and eosinophilic activation in children with
asthma [5].ISRN Pediatrics 3
Table 2: Diagnosis screening results being displayed concomitantly.
Sensitivity Speciﬁcity Positive predictive Negative predictive Accuracy Relative risk
Total IgE 54.88 69.23 84.91 32.73 58.33 1.26
h sECP 68.29 84.62 93.33 45.83 72.22 1.72
IgE and ECP 92.68 57.69 87.36 71.43 84.26 3.06
In a prospective study, 33 children with wheezing but
without atopy, 15 children with upper respiratory tract
infection but without atopy, and 18 healthy children were
compared in terms of sECP values. The sECP values of
the group with wheezing were found to be statistically
signiﬁcantly higher in comparison to the other two groups.
Observations that lasted for one year revealed the beginning
of the development of asthma in the group with wheezing.
In conclusion, the sECP measurements in children with
wheezing were considered to have predictive value for the
development of asthma [6].
In a prospective study conducted on 92 patients in
Finland, sECP was found to be speciﬁcally high in acute
attacks of wheezing [7].
In 2010, in Italy, the sECP levels of 441 cases of res-
piratory tract disease were investigated retrospectively and
compared to 33 healthy infants. The sECP levels were found
to be signiﬁcantly higher in cases with asthma. However, the
sECP levels were not found to be high in respiratory tract
diseases other than asthma. The sECP sensitivity was found
to be 70%, and speciﬁcity in predicting asthma was found to
be 74% [8]. In our study, sensitivity was found to be 68.29%,
while speciﬁcity was found to be 84.62%.
Numerous other articles, apart from those mentioned
above, have also reported that the scope of sECP is a helpful
parameter in displaying the inﬂammation of the respiratory
tract and eosinophilic activation in children with asthma.
However, the number of articles that have presented an
opposite opinion has increased in recent years: for example,
in a study conducted in 2007, an account was given of 47
cases of hospital admission for wheezy breathing (group 1);
atleast3wheezingattackshadoccurredin43cases(group2);
and hospital admission, due to a cause other than respiratory
systemdiseases,hadoccurredin43cases(thecontrolgroup).
In the groups (1 and 2) with wheezing, sECP levels were
found to be statistically signiﬁcantly higher. The groups with
wheezing were investigated, and no statistically signiﬁcant
diﬀerence was found in sECP between the group with a ﬁrst
attack and the group with the recurrent attacks [9].
The sECP levels and eosinophil counts of a total of
25 cases having a ﬁrst bronchiolitis attack, aged one to 17
months, were evaluated. At the end of the followup, which
lasted for three years, eight of the 25 had developed asthma.
However, 15 of this group did not develop asthma. No
signiﬁcant diﬀerence was observed between the sECP levels
and eosinophil counts of the two groups [10]. Khadadah et
al. [11] evaluated the total IgE and sECP levels, as well as
the peripheral eosinophilic count, concomitantly in a study
involving 101 patients with asthma.
In our study, the concomitant evaluation of the total IgE
and sECP revealed a sensitivity rate of 92.68%, a negative
predictive value of 71.48%, and an accuracy rate of 84.26%.
The highest relative risk was 3.06, due to persistent wheezing
at the end of the two-year followup period, which gave a rate
of 73.5%.
It is now suggested that early treatment of bronchial
inﬂammation, soon after the onset of the disease, may arrest
itsprogress[12].Mostasthmaticsstartdevelopingsymptoms
at age of 2-3 years, but 60% of children wheezing at this
age will be asymptomatic when they are 6 years old, so it
wouldbeofinteresttoknowwhichchildrenhaveatransitory
disease and which have early childhood asthma. The latter
group would probably beneﬁt from anti-inﬂammatory drug
treatment.
Our ﬁndings suggest that eosinophilic inﬂammation is
present from the onset of the disease in the group of
wheezing young children who will continue with wheez-
ing episodes at age 5-6 years. Determination of serum
eosinophilic cationic protein and total IgE, concomitantly,
was not evaluated on the basis of presence of allergic rhinitis,
atopic dermatitis, or history of maternal asthma. This may
help to determine which children will continue with asthma
and could therefore beneﬁt from a more aggressive approach
to treatment and which children merit a more conservative
approach, as their disease will probably be transitory. Studies
with more patients and a longer follow-up period are needed
to conﬁrm these results.
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